Has Synergy Pharmaceuticals Become A Takeout Candidate Following 2 Recent Phase 3 Trial Successes?

By: via Benzinga
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) has announced the results from its second pivotal Phase 3 trial for plecanatide in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.